USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/7442
Title: Tratamentul personalizat în carcinomul mamar
Other Titles: Personalized therapy for breast cancer
Authors: Fulga, V.
Keywords: breast cancer;personalized therapy;molecular subtypes
Issue Date: 2014
Publisher: The Scientific Medical Association of the Republic of Moldova
Citation: FULGA, V. Tratamentul personalizat în carcinomul mamar. In: Curierul Medical. 2014, vol. 57, no 5, pp. 73-76. ISSN 1875-0666.
Abstract: Background: Breast carcinoma represents the most common cancer worldwide and the second main cause of death among women. It’s a complex disease characterized by many morphological, clinical and molecular features. Traditionally, this disease has been classified according to histopathologic criteria, known as the tumor, node and metastasis staging system. Because the classic concept was focusing only on the tumor morphology, it could not fully capture the diversity of the disease. Another classification system, based on hormone receptors and gene expression profiling of different breast cancers types have been developed. This classification dictates the optimal therapeutic approach and it is based on immunohistochemical markers, such as the estrogen receptor, the progesterone receptor, the human epidermal growth factor receptor 2, basal cytokeratin CK5 and proliferation marker Ki67. New technologies, polymerase chain reaction, microarrays make possible identification of new biomarkers involved in breast cancer development, survival and invasion, which can be gradually incorporated into clinical trials. The aim of this study is to highlight the progress achieved in the field of diagnosis and management of breast cancer, using molecular analysis and intrinsic subtypes, commonly accepted in oncology practice. Conclusions: Mammary carcinoma represents heterogenous pathologic entity that is characterised by genetic abnormalities and specific intra/ extracelullar pathways, grouped in intrinsic molecular subtypes identifiable with the help of immunohistochemistry. Modern therapy is based on molecular subtypes; meanwhile their descrimination represents the initial step of personalised treatment.
metadata.dc.relation.ispartof: Curierul Medical
URI: http://repository.usmf.md/handle/20.500.12710/7442
http://moldmedjournal.md/wp-content/uploads/2016/09/Cm-5-Electronic-version-2.pdf
ISSN: 1875-0666
Appears in Collections:Curierul Medical, 2014, Vol. 57, Nr. 5

Files in This Item:
File Description SizeFormat 
Personalized_therapy_for_breast_cancer.pdf178.73 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback